Stenocare A/S

kr 0.67As of Sun 8 Nov 2026, 12:00 UTC
CPH:STENOHealthcare
Country Denmark
PE (Fwd) •••
TSR 6Y CAGR (38.63%)
Div yield —
ROE (34.20%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.70
PE TTM —
TSR TTM (55.66%)
Mkt cap kr 29.11M
ROIC (16.40%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.65
(3.49%)
(12.22%)
Hold 8|7|11|3|2
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.01
0.01
0.01
0.01
1.02%
3.46%
3.54%
11.37%
Revenuekr M
3.574
3.588
3.679
3.633
12.78%
12.38%
9.62%
3.99%
Peers (US$4.340M)
Cap (US$)
PE
3.638M
18.36x
4.390M
—
Capital
TTM
5Y
10Y
Leveragex
0.472
—
—
EBIT/Intx
0.631
0.240
0.243
Own earn%
66.73
9.03
7.53
Sh yield%
36.83
43.97
43.71
Owners
Insiders/Inst%
4.21
59.74
Short interest%
3.04
SBC / revenue%
2.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
13–24
$1 testx
—
Incr. ROIC%
112